-
2
-
-
38149061019
-
Oral contraceptives in polycystic ovary syndrome: Risk-benefit assessment
-
Yildiz BO: Oral contraceptives in polycystic ovary syndrome: risk-benefit assessment. Semin Reprod Med 2008;26:111-120.
-
(2008)
Semin Reprod Med
, vol.26
, pp. 111-120
-
-
Yildiz, B.O.1
-
5
-
-
77953121511
-
Mechanisms of estrogeninduced venous thromboembolism
-
Tchaikovski SN, Rosing J: Mechanisms of estrogeninduced venous thromboembolism. Thromb Res 2010;126:5-11.
-
(2010)
Thromb Res
, vol.126
, pp. 5-11
-
-
Tchaikovski, S.N.1
Rosing, J.2
-
6
-
-
0033014691
-
Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives
-
Harris GM, Stendt CL, Vollenhoven BJ, Gan TE, Tipping PG: Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives. Am J Hematol 1999;60:175-180.
-
(1999)
Am J Hematol
, vol.60
, pp. 175-180
-
-
Harris, G.M.1
Stendt, C.L.2
Vollenhoven, B.J.3
Gan, T.E.4
Tipping, P.G.5
-
7
-
-
0030934739
-
Oral contraceptives and venous thrombosis: Different sensitivities to activated protein C in women using second-and thirdgeneration oral contraceptives
-
Rosing J, Tans G, Nicolaes GA, Thomassen MC, van Oerle R, van der Ploeg PM, Heijnen P, Hamulyak K, Hemker HC: Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second-and thirdgeneration oral contraceptives. Br J Haematol 1997; 97:233-238.
-
(1997)
Br J Haematol
, vol.97
, pp. 233-238
-
-
Rosing, J.1
Tans, G.2
Nicolaes, G.A.3
Thomassen, M.C.4
Van Oerle, R.5
Van Der Ploeg, P.M.6
Heijnen, P.7
Hamulyak, K.8
Hemker, H.C.9
-
8
-
-
69949103268
-
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: Results of the MEGA case-control study
-
van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR: The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 2009; 339:b2921.
-
(2009)
BMJ
, vol.339
-
-
Van Hylckama Vlieg, A.1
Helmerhorst, F.M.2
Vandenbroucke, J.P.3
Doggen, C.J.4
Rosendaal, F.R.5
-
9
-
-
79958149914
-
Estrogen and thrombosis: Controversies and common sense
-
DeLoughery TG: Estrogen and thrombosis: controversies and common sense. Rev Endocr Metab Disord 2011;12:77-84.
-
(2011)
Rev Endocr Metab Disord
, vol.12
, pp. 77-84
-
-
Deloughery, T.G.1
-
10
-
-
0141832939
-
Estrogens, progestogens and thrombosis
-
Rosendaal FR, Van Hylckama Vlieg A, Tanis BC, Helmerhorst FM: Estrogens, progestogens and thrombosis. J Thromb Haemost 2003;1:1371-1380.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 1371-1380
-
-
Rosendaal, F.R.1
Van Hylckama Vlieg, A.2
Tanis, B.C.3
Helmerhorst, F.M.4
-
11
-
-
0142122810
-
Oral contraceptives use and the risk of myocardial infarction: A meta-analysis
-
7
-
Khader YS, Rice J, John L, Abueita O: Oral contraceptives use and the risk of myocardial infarction: a meta-analysis. Contraception 2003;68:11-1 7.
-
(2003)
Contraception
, vol.68
, pp. 11-21
-
-
Khader, Y.S.1
Rice, J.2
John, L.3
Abueita, O.4
-
12
-
-
23044493043
-
Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: A meta-analysis
-
Baillargeon JP, McClish DK, Essah PA, Nestler JE: Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab 2005;90:3863-3870.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 3863-3870
-
-
Baillargeon, J.P.1
McClish, D.K.2
Essah, P.A.3
Nestler, J.E.4
-
13
-
-
0030772383
-
Use of low-dose oral contraceptives and stroke in young women
-
Schwartz SM, Siscovick DS, Longstreth WT Jr, Psaty BM, Beverly RK, Raghunathan TE, Lin D, Koepsell TD: Use of low-dose oral contraceptives and stroke in young women. Ann Intern Med 1997;127:596-603.
-
(1997)
Ann Intern Med
, vol.127
, pp. 596-603
-
-
Schwartz, S.M.1
Siscovick, D.S.2
Longstreth Jr., W.T.3
Psaty, B.M.4
Beverly, R.K.5
Raghunathan, T.E.6
Lin, D.7
Koepsell, T.D.8
-
14
-
-
33646491436
-
Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: Data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation
-
Merz CN, Johnson BD, Berga S, Braunstein G, Reis SE, Bittner V: Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Fertil Steril 2006; 85:1425-1431.
-
(2006)
Fertil Steril
, vol.85
, pp. 1425-1431
-
-
Merz, C.N.1
Johnson, B.D.2
Berga, S.3
Braunstein, G.4
Reis, S.E.5
Bittner, V.6
-
15
-
-
79958137401
-
Metabolic effects of contraceptive steroids
-
Sitruk-Ware R, Nath A: Metabolic effects of contraceptive steroids. Rev Endocr Metab Disord 2011;12: 63-75.
-
(2011)
Rev Endocr Metab Disord
, vol.12
, pp. 63-75
-
-
Sitruk-Ware, R.1
Nath, A.2
-
16
-
-
0036598136
-
Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: The CARDIA Study. Coronary Artery Risk Development in Young Adults
-
Kim C, Siscovick DS, Sidney S, Lewis CE, Kiefe CI, Koepsell TD: Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: the CARDIA Study. Coronary Artery Risk Development in Young Adults. Diabetes Care 2002;25:1027-1032.
-
(2002)
Diabetes Care
, vol.25
, pp. 1027-1032
-
-
Kim, C.1
Siscovick, D.S.2
Sidney, S.3
Lewis, C.E.4
Kiefe, C.I.5
Koepsell, T.D.6
-
17
-
-
0026674517
-
Oral contraceptive use and the risk of type 2 (noninsulin-dependent) diabetes mellitus in a large prospective study of women
-
Rimm EB, Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Hennekens CH, Speizer FE: Oral contraceptive use and the risk of type 2 (noninsulin-dependent) diabetes mellitus in a large prospective study of women. Diabetologia 1992;35: 967-972.
-
(1992)
Diabetologia
, vol.35
, pp. 967-972
-
-
Rimm, E.B.1
Manson, J.E.2
Stampfer, M.J.3
Colditz, G.A.4
Willett, W.C.5
Rosner, B.6
Hennekens, C.H.7
Speizer, F.E.8
-
18
-
-
0030742083
-
Oral contraceptives and ovulatory causes of delayed fertility
-
Chasan-Taber L, Willett WC, Stampfer MJ, Spiegelman D, Rosner BA, Hunter DJ, Colditz GA, Manson JE: Oral contraceptives and ovulatory causes of delayed fertility. Am J Epidemiol 1997;146: 258-265.
-
(1997)
Am J Epidemiol
, vol.146
, pp. 258-265
-
-
Chasan-Taber, L.1
Willett, W.C.2
Stampfer, M.J.3
Spiegelman, D.4
Rosner, B.A.5
Hunter, D.J.6
Colditz, G.A.7
Manson, J.E.8
-
19
-
-
84155163090
-
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRMSponsored 3rd PCOS Consensus Workshop Group
-
e25
-
Fauser BC, Tarlatzis BC, Rebar RW, et al: Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRMSponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012;97:28-38, e25.
-
Fertil Steril 2012
, vol.97
, pp. 28-38
-
-
Fauser, B.C.1
Tarlatzis, B.C.2
Rebar, R.W.3
-
20
-
-
77954870760
-
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis
-
Moran LJ, Misso ML, Wild RA, Norman RJ: Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010;16:347-363.
-
(2010)
Hum Reprod Update
, vol.16
, pp. 347-363
-
-
Moran, L.J.1
Misso, M.L.2
Wild, R.A.3
Norman, R.J.4
-
21
-
-
77449124834
-
Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis
-
Mak W, Dokras A: Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis. Semin Thromb Hemost 2009;35:613-620.
-
(2009)
Semin Thromb Hemost
, vol.35
, pp. 613-620
-
-
Mak, W.1
Dokras, A.2
-
22
-
-
8744223271
-
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?
-
Orio F Jr, Palomba S, Cascella T, Tauchmanova L, Nardo LG, Di Biase S, Labella D, Russo T, Savastano S, Tolino A, Zullo F, Colao A, Lombardi G: Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? Reprod Biomed Online 2004;9:505-510.
-
(2004)
Reprod Biomed Online
, vol.9
, pp. 505-510
-
-
Orio Jr., F.1
Palomba, S.2
Cascella, T.3
Tauchmanova, L.4
Nardo, L.G.5
Di Biase, S.6
Labella, D.7
Russo, T.8
Savastano, S.9
Tolino, A.10
Zullo, F.11
Colao, A.12
Lombardi, G.13
-
23
-
-
47249099737
-
Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population
-
Jalovaara K, Santaniemi M, Timonen M, Jokelainen J, Kesaniemi YA, Ukkola O, Keinanen-Kiukaanniemi S, Rajala U: Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population. Metabolism 2008;57:1130-1134.
-
(2008)
Metabolism
, vol.57
, pp. 1130-1134
-
-
Jalovaara, K.1
Santaniemi, M.2
Timonen, M.3
Jokelainen, J.4
Kesaniemi, Y.A.5
Ukkola, O.6
Keinanen-Kiukaanniemi, S.7
Rajala, U.8
-
24
-
-
33745183175
-
Cardiovascular risk in women with polycystic ovary syndrome
-
Orio F, Palomba S, Colao A: Cardiovascular risk in women with polycystic ovary syndrome. Fertil Steril 2006;86(suppl 1):S20-S21.
-
(2006)
Fertil Steril
, vol.86
, Issue.SUPPL. 1
-
-
Orio, F.1
Palomba, S.2
Colao, A.3
-
25
-
-
0038307320
-
Polycystic ovary syndrome and cardiovascular disease: A premature association?
-
Legro RS: Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 2003;24:302-312.
-
(2003)
Endocr Rev
, vol.24
, pp. 302-312
-
-
Legro, R.S.1
-
26
-
-
0028888951
-
Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome
-
Falsetti L, Pasinetti E: Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 1995;74:56-60.
-
(1995)
Acta Obstet Gynecol Scand
, vol.74
, pp. 56-60
-
-
Falsetti, L.1
Pasinetti, E.2
-
27
-
-
0032931526
-
The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment
-
Pasquali R, Gambineri A, Anconetani B, Vicennati V, Colitta D, Caramelli E, Casimirri F, Morselli-Labate AM: The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment. Clin Endocrinol (Oxf) 1999;50:517-527.
-
(1999)
Clin Endocrinol (Oxf)
, vol.50
, pp. 517-527
-
-
Pasquali, R.1
Gambineri, A.2
Anconetani, B.3
Vicennati, V.4
Colitta, D.5
Caramelli, E.6
Casimirri, F.7
Morselli-Labate, A.M.8
-
28
-
-
78650715566
-
The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: A systematic review and meta-analysis of observational studies
-
Halperin IJ, Kumar SS, Stroup DF, Laredo SE: The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies. Hum Reprod 2011;26:191-201.
-
(2011)
Hum Reprod
, vol.26
, pp. 191-201
-
-
Halperin, I.J.1
Kumar, S.S.2
Stroup, D.F.3
Laredo, S.E.4
-
29
-
-
0344286476
-
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome
-
Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J: Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141-146.
-
(1999)
Diabetes Care
, vol.22
, pp. 141-146
-
-
Ehrmann, D.A.1
Barnes, R.B.2
Rosenfield, R.L.3
Cavaghan, M.K.4
Imperial, J.5
-
30
-
-
21244465167
-
Changes in glucose tolerance over time in women with polycystic ovary syndrome: A controlled study
-
Legro RS, Gnatuk CL, Kunselman AR, Dunaif A: Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 2005;90:3236-3242.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 3236-3242
-
-
Legro, R.S.1
Gnatuk, C.L.2
Kunselman, A.R.3
Dunaif, A.4
-
31
-
-
30344448576
-
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome
-
Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN: Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91: 48-53.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 48-53
-
-
Ehrmann, D.A.1
Liljenquist, D.R.2
Kasza, K.3
Azziz, R.4
Legro, R.S.5
Ghazzi, M.N.6
-
32
-
-
84865472733
-
Polycystic ovary syndrome is a risk factor for type 2 diabetes: Results from a longterm prospective study
-
Epub ahead of print
-
Gambineri A, Patton L, Altieri P, Pagotto U, Pizzi C, Manzoli L, Pasquali R: Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a longterm prospective study. Diabetes 2012, Epub ahead of print.
-
(2012)
Diabetes
-
-
Gambineri, A.1
Patton, L.2
Altieri, P.3
Pagotto, U.4
Pizzi, C.5
Manzoli, L.6
Pasquali, R.7
-
33
-
-
34447096147
-
Metformin versus oral contraceptive pill in polycystic ovary syndrome: A Cochrane review
-
Costello MF, Shrestha B, Eden J, Johnson NP, Sjoblom P: Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review. Hum Reprod 2007;22:1200-1209.
-
(2007)
Hum Reprod
, vol.22
, pp. 1200-1209
-
-
Costello, M.F.1
Shrestha, B.2
Eden, J.3
Johnson, N.P.4
Sjoblom, P.5
-
34
-
-
56549114144
-
The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: An updated systematic review
-
Jing Z, Liang-Zhi X, Tai-Xiang W, Ying T, Yu-Jian J: The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review. Gynecol Endocrinol 2008;24:590-600.
-
(2008)
Gynecol Endocrinol
, vol.24
, pp. 590-600
-
-
Jing, Z.1
Liang-Zhi, X.2
Tai-Xiang, W.3
Ying, T.4
Yu-Jian, J.5
-
35
-
-
80052421044
-
Timing of hormone therapy, type of menopause, and coronary disease in women: Data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation
-
Shufelt CL, Johnson BD, Berga SL, Braunstein GD, Reis SE, Bittner V, Yang Y, Pepine CJ, Sharaf BL, Sopko G, Kelsey SF, Merz CN: Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Menopause 2011;18:943-950.
-
(2011)
Menopause
, vol.18
, pp. 943-950
-
-
Shufelt, C.L.1
Johnson, B.D.2
Berga, S.L.3
Braunstein, G.D.4
Reis, S.E.5
Bittner, V.6
Yang, Y.7
Pepine, C.J.8
Sharaf, B.L.9
Sopko, G.10
Kelsey, S.F.11
Merz, C.N.12
|